Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights
Mostafa M. Elbadawi, Wagdy M. Eldehna, Amer Ali Abd El‐Hafeez, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 37, Iss. 1, pp. 355-378
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Roles and inhibitors of FAK in cancer: current advances and future directions
Hui-Hui Hu, Saiqi Wang, Hai-Li Shang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 19
Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment
Xianbo Wu, Jie Wang, Qi Liang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113116-113116
Open Access | Times Cited: 35
The Development of FAK Inhibitors: A Five-Year Update
Andrea Spallarossa, Bruno Tasso, Eleonora Russo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6381-6381
Open Access | Times Cited: 35
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, andin silicostudies
Samia M. Al-Muntaser, Ahmed A. Al‐Karmalawy, Abeer M. El‐Naggar, et al.
RSC Advances (2023) Vol. 13, Iss. 18, pp. 12184-12203
Open Access | Times Cited: 25
Targeting Focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degraders
Xiao Wang, Na Li, Yunhe Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116678-116678
Closed Access | Times Cited: 7
Pyrimidine-based dual-target inhibitors targeting epidermal growth factor receptor for overcoming drug resistance in cancer therapy(2006-present)
Yufeng An, Xinya Lv, Shidi Xu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117268-117268
Closed Access
Design, synthesis, in vitro, and in silico studies of novel isatin-hybrid hydrazones as potential triple-negative breast cancer agents
Iqra Munir, Zahra Batool, Faizullah Khan, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 948-965
Open Access
Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties
Samaa Saied, Moataz A. Shaldam, Mostafa M. Elbadawi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115707-115707
Closed Access | Times Cited: 19
Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer
Wagdy M. Eldehna, Eslam Essam Mohammed, Ghada H. Al-Ansary, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115538-115538
Closed Access | Times Cited: 16
Identification of 2-(N-aryl-1,2,3-triazol-4-yl) quinoline derivatives as antitubercular agents endowed with InhA inhibitory activity
Ahmed Sabt, Maha-Hamadien Abdulla, Manal S. Ebaid, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 4
Discovery of new sulfonamide-tethered 2-aryl-4-anilinoquinazolines as the first-in-class dual carbonic anhydrase and EGFR inhibitors
Wagdy M. Eldehna, Zainab M. Elsayed, Andrea Ammara, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135010-135010
Closed Access | Times Cited: 4
Antibacterial and antibiofilm activity of permanently ionized quaternary ammonium fluoroquinolones
Joanna Fedorowicz, Cristina D. Cruz, Małgorzata Morawska, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115373-115373
Open Access | Times Cited: 13
Dual roles of FAK in tumor angiogenesis: A review focused on pericyte FAK
Jingyu Zhang, Wěi Li, Wenxin Wang, et al.
European Journal of Pharmacology (2023) Vol. 947, pp. 175694-175694
Closed Access | Times Cited: 12
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profile
Camilla Pecoraro, Daniela Carbone, Fabio Scianò, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 10, pp. 1278-1294
Open Access | Times Cited: 3
Modified pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as EGFRWT and EGFRT790M inhibitors: Design, synthesis, and anti-cancer evaluation
Eman S. Nossier, Rania A. Alasfoury, Mohamed Hagras, et al.
Journal of Molecular Structure (2022) Vol. 1270, pp. 133971-133971
Closed Access | Times Cited: 16
Identification of Novel EGFR Inhibitors for the Targeted Therapy of Colorectal Cancer Using Pharmacophore Modelling, Docking, Molecular Dynamic Simulation and Biological Activity Prediction
Amrutha Krishnan K., Sudha George Valavi, Amitha Joy
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 4, pp. 263-279
Closed Access | Times Cited: 2
Zn complexed on hybrid manganese doped cobalt ferrite nanoparticles covered by silica as a catalyst in the synthesis of 2-amino-4H-pyran and N- arylquinoline derivatives
Najmieh Ahadi, Akbar Mobinikhaledi, Amir Hossain Ebrahimi
Heliyon (2024) Vol. 10, Iss. 9, pp. e30620-e30620
Open Access | Times Cited: 2
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: Synthesis, mechanistic Insights and promising antitumor and safety profile
Daniela Carbone, Camilla Pecoraro, Fabio Scianò, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
FAK inhibitors in cancer, a patent review – an update on progress
Ya‐Xi Ye, Yuyao Cao, Lisheng Xu, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 8, pp. 593-610
Closed Access | Times Cited: 2
Microwave-assisted synthesis, spectroscopic characterization, and biological evaluation of fused thieno[2,3-d]pyrimidines as potential anti-cancer agents targeting EGFRWT and EGFRT790M
Moustafa O. Aboelez, Moumen S. Kamel, Amany Belal, et al.
Molecular Diversity (2022) Vol. 27, Iss. 2, pp. 901-917
Closed Access | Times Cited: 14
Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review
Chao Wang, Yujing Zhang, Tingting Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127440-127440
Closed Access | Times Cited: 7
In Silico Repurposing of a Novel Inhibitor (drug) of EGFR and VEGFR-2 Kinases of Cancer by Pharmacokinetics, Toxicity, Molecular Docking, and Molecular Dynamics Simulation
Mona H. Ibraheim, Ibrahim Maher, Ibrahim Khater
Applied Biochemistry and Biotechnology (2024)
Closed Access | Times Cited: 1
Development of Novel Focal Adhesion Kinase (FAK) Inhibitors for Targeting Cancer: Structural Insights and Therapeutic Potential
Yingnan Li, Yuming Zhang, Jifa Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116913-116913
Closed Access | Times Cited: 1
Camptothecin structure simplification elaborated new imidazo[2,1-b]quinazoline derivative as a human topoisomerase I inhibitor with efficacy against bone cancer cells and colon adenocarcinoma
Ahmed I. Khodair, Salwa M. El‐Hallouty, Brittnee Cagle-White, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116049-116049
Closed Access | Times Cited: 4
Direct Regioselective Hydro(hetero)arylation/Cyclocondensation Reactions of β-(2-Aminophenyl)-α,β-ynones by Means of Transition-Metal Catalysis/Brønsted Acid Synergism: Experimental Results and Computational Insights
Vincenzo Marsicano, Antonio Arcadi, Massimiliano Aschi, et al.
The Journal of Organic Chemistry (2023) Vol. 88, Iss. 11, pp. 6857-6867
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top